IL2 and kidney cancer: The high levels of IL2RA in activated circulating immune cells and Tregs is exploited for IL-2 immunotherapy of tumors and autoimmune diseases; and certain polymorphisms of IL2RA are related to the risk of kidney cancer (35, 36).